HomeCompareNRWS vs JNJ

NRWS vs JNJ: Dividend Comparison 2026

NRWS yields 2000000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NRWS wins by $4.879226400974806e+39M in total portfolio value
10 years
NRWS
NRWS
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full NRWS calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NRWS vs JNJ

📍 NRWS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNRWSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NRWS + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NRWS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NRWS
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, NRWS beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NRWS + JNJ for your $10,000?

NRWS: 50%JNJ: 50%
100% JNJ50/50100% NRWS
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NRWS
No analyst data
Altman Z
-25.9
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NRWS buys
0
JNJ buys
0
No recent congressional trades found for NRWS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNRWSJNJ
Forward yield2000000.00%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$4.879226400974806e+39M$20.0K
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$827.78
Total dividends collected$4.879195005460081e+39M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NRWS vs JNJ ($10,000, DRIP)

YearNRWS PortfolioNRWS Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$200,010,700$200,000,000.00$10,676$355.77+$200.00MNRWS
2$3,738,731,768,458$3,738,517,757,009.35$11,407$389.39+$3738731.76MNRWS
3$65,315,062,866,930,490$65,311,062,423,938,240.00$12,198$426.53+$65315062866.92MNRWS
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$13,056$467.62+$1066400830062625.00MNRWS
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$13,987$513.12+$16272182796453826560.00MNRWS
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$14,998$563.56+$2.3205424011366188e+23MNRWS
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$16,098$619.52+$3.0927990661046884e+27MNRWS
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$17,295$681.69+$3.8524105697352695e+31MNRWS
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$18,599$750.82+$4.484688260147987e+35MNRWS
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$20,022$827.78+$4.879226400974806e+39MNRWS

NRWS vs JNJ: Complete Analysis 2026

NRWSStock

Narrowstep Inc., along with its subsidiaries, offers Internet-based video content delivery services in Europe, Asia, and the United States. Its technology platform, TelvOS, enables the delivery of video content and television-like programming to mobile, wireless, the Internet, broadband, and broadcast services. The TelvOS system provides a platform to owners and users video content that enables to reach specific audiences by narrowcasting; and enables to commercialize video-based content through directed advertising, sponsorship, pay-per-view, subscription, and/or e-commerce. It also offers AdServer, an online system that enables the commercialization of broadband video distribution by providing the control and management of advertising content; PayGate, an interface between the TelvOS platform and payment gateways; NCoder, an encoding hardware solution that provides direct encoding capability for video content and attaches to a client's edit machine or network; and DownloadServer, a product integrated within TelvOS to offer downloads of various media. The company was incorporated in 2002 and is based in Princeton, New Jersey. It has an additional office in London, United Kingdom. Narrowstep Inc. operates as a subsidiary of Piksel Inc.

Full NRWS Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NRWS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NRWS vs SCHDNRWS vs JEPINRWS vs ONRWS vs KONRWS vs MAINNRWS vs ABBVNRWS vs MRKNRWS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.